We are live on ! Find out more
FCM

Flinton Capital Management Portfolio holdings

AUM $3.22B
1-Year Est. Return 4.75%
This Fund
S&P 500
This Quarter Est. Return
+3.44%
1 Year Est. Return
+4.75%
3 Year Est. Return
+55.55%
5 Year Est. Return
10 Year Est. Return
AUM
$3.18B
AUM Growth
+$130M
Cap. Flow
+$52.8M
Cap. Flow %
1.66%
Top 10 Hldgs %
29.28%
Holding
907
New
33
Increased
332
Reduced
204
Closed
26

Top Sells

Rank Stock Value
1
SNA icon
Snap-on
SNA
+$18.6M
2
AAPL icon
Apple
AAPL
+$17.5M
3
RTX icon
RTX Corp
RTX
+$13.8M
4
DD icon
DuPont de Nemours
DD
+$8.59M
5
BNY
Bank of New York Mellon
BNY
+$7.53M

Sector Composition

Rank Sector Weight
1 Technology 22.98%
2 Healthcare 18.03%
3 Financials 13.23%
4 Industrials 11.81%
5 Consumer Discretionary 7.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVBG
851
DELISTED
Everbridge, Inc. Common Stock
EVBG
$30K ﹤0.01%
336
RPT
852
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$30K ﹤0.01%
2,464
CHRS icon
853
Coherus Oncology
CHRS
$222M
$29K ﹤0.01%
1,296
GDDY icon
854
GoDaddy
GDDY
$11.7B
$29K ﹤0.01%
408
KALV
855
DELISTED
KalVista Pharmaceuticals
KALV
$29K ﹤0.01%
1,292
UPLD icon
856
Upland Software
UPLD
$13.1M
$25K ﹤0.01%
56
CSOD
857
DELISTED
Cornerstone OnDemand, Inc.
CSOD
$21K ﹤0.01%
364
ENV
858
DELISTED
ENVESTNET, INC.
ENV
$20K ﹤0.01%
288
ALEC icon
859
Alector
ALEC
$168M
$19K ﹤0.01%
980
WVE icon
860
Wave Life Sciences
WVE
$1.13B
$19K ﹤0.01%
720
+144
+25% +$4.04K
CBAY
861
DELISTED
Cymabay Therapeutics
CBAY
$19K ﹤0.01%
2,686
REPL icon
862
Replimune Group
REPL
$1B
$17K ﹤0.01%
1,148
CYCN icon
863
Cyclerion Therapeutics
CYCN
$15.1M
$16K ﹤0.01%
+68
New +$19.2K
KGC icon
864
Kinross Gold
KGC
$27.8B
$16K ﹤0.01%
4,384
+880
+25% +$2.96K
LOVE
865
DELISTED
LoveSac
LOVE
$16K ﹤0.01%
+528
New +$18.1K
AQST icon
866
Aquestive Therapeutics
AQST
$476M
$15K ﹤0.01%
3,604
QTWO icon
867
Q2 Holdings
QTWO
$3.89B
$15K ﹤0.01%
192
BB icon
868
BlackBerry
BB
$4.99B
$13K ﹤0.01%
1,856
+384
+26% +$3.33K
MEOH icon
869
Methanex
MEOH
$4.2B
$13K ﹤0.01%
304
+16
+6% +$802
XLI icon
870
State Street Industrial Select Sector SPDR ETF
XLI
$33.3B
$13K ﹤0.01%
168
-476
-74% -$36.2K
TBPH icon
871
Theravance Biopharma
TBPH
$874M
$12K ﹤0.01%
748
AZPN
872
DELISTED
ASPEN TECHNOLOGY INC
AZPN
$12K ﹤0.01%
96
-336
-78% -$42K
CLDR
873
DELISTED
Cloudera, Inc.
CLDR
$11K ﹤0.01%
2,108
CHMA
874
DELISTED
Chiasma, Inc. Common Stock
CHMA
$11K ﹤0.01%
1,428
+140
+11% +$918
ESLT icon
875
Elbit Systems
ESLT
$38.9B
$10K ﹤0.01%
68

Similar funds

Flinton Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Flinton Capital Management held 907 positions worth $3.18B, up 4.3% from $3.05B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Flinton Capital Management's Q2 2019 filing shows 33 new, 332 increased, 204 reduced and 26 closed positions. Its largest new stake was Dow Inc: 38,472 shares worth $1.9M. The largest sale was Snap-on, an estimated $18.6M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.

  • Flinton Capital Management's largest Q2 2019 buy was Dow Inc: 38,472 shares worth $1.9M.
  • Flinton Capital Management added most to iShares Russell 1000 Growth ETF in Q2 2019, an estimated $40M increase.
  • Flinton Capital Management's biggest Q2 2019 reduction was Snap-on, cutting an estimated $18.6M.
  • Flinton Capital Management fully exited L3Harris in Q2 2019, selling an estimated $5.83M.
  • Flinton Capital Management's ten largest holdings make up 29% of its $3.18B portfolio in Q2 2019.
  • Flinton Capital Management opened 33 new positions and closed 26 in Q2 2019.
  • Flinton Capital Management's portfolio value rose 4.3% quarter-over-quarter to $3.18B.

Based on Flinton Capital Management's 13F filing for Q2 2019, filed 13 Aug 2019.